What you should know
BRCA1 and BRCA2 are often discussed in relation to breast and ovarian cancer, but some inherited variants also matter for prostate cancer risk and treatment decisions.
Why this matters
Risk factors help guide conversations but do not determine a person’s future. Having a risk factor does not mean cancer is inevitable, and having no known risk factors does not eliminate risk.
People often encounter conflicting information about prostate cancer online. It is helpful to consider how a claim was studied, whether it comes from a recognized health organization, and whether it addresses screening, diagnosis, treatment, or supportive care. These are different questions that may require different medical decisions.
What to discuss with your care team
Ask how this topic relates to your age, personal and family history, previous tests, current symptoms, and healthcare goals. If a test or treatment is proposed, ask what the result could change, what uncertainties remain, and when follow-up is needed.
Tell your healthcare team about breast, ovarian, pancreatic, and prostate cancers in the family.
Educational information only, not medical advice. This article summarizes an established health topic for a 2026 resource collection; it is not a claim of a new 2026 study or an individualized recommendation. Review linked source guidance for updates.